The effect of selenium on the prognosis of patients with Keshan disease

A study on the effct of selenium on the prognosis of patients with Keshan disease and the molecule mechanism

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-PRRC-09000453

Enrollment

Unknown

Registered

2009-06-19

Start date

2009-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keshan Disease

Interventions

a:selenious yeast

b:selenious yeast

Eligibility

Sex/Gender

All

Age

No minimum to 80 Years

Inclusion criteria

Inclusion criteria: The chronic Keshan disease patients; heart function II-III, or patients with heart function IV in stable condition; age less than 80.

Exclusion criteria

Exclusion criteria: Difficult in walking; not good mental status; severe abnormal electrocardiogram, such as atrial fibrillation with ventricular rate out of control, persistent ventricular tachycardia; severe aorta stenosis; fresh myocardial infarction; severe liver or kidney disease; congenital cardiopathy.

Design outcomes

Primary

Measure	Time frame
effective rate;survival rat;	—

Secondary

Measure	Time frame
the score of quality of life with heart failur;	—

Countries

China

Contacts

Public ContactTong Wang

wangtong@ems.hrbmu.edu.cn+86 0451 86657264

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026